Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eligen Technology
Eligen Technology
Novartis initiates second phase-I trial for oral PTH1-34 to treat postmenopausal osteoporosis
Pharmabiz
Sat, 04/17/10 - 12:53 pm
Novartis
Emisphere
Eligen Technology
PTH1-34
osteoporosis
